Clinical trial

Ultrasound Guided Modified Versus Conventional Serratus Anterior Plane Block as a Preemptive Analgesia for Unilateral Video-Assisted Thoracoscopic Surgery

Name

ZU-IRB # 10061

Description

comparing preemptive analgesia with ultrasound guided modified serratus anterior plane block versus ultrasound guided serratus anterior plane block

Trial arms

Trial start

2022-12-02

Estimated PCD

2023-10-02

Trial end

2023-10-30

Status

Recruiting

Treatment

25 ml of bupivacaine 0.25% via serratus anterior block

patients will receive conventional serratus anterior plane block with a volume of 25 ml of bupivacaine 0.25% followed by induction of general anesthesia,

Arms:

SAP block group

25 ml of bupivacaine 0.25% via modified serratus anterior palne block

patients will receive modified serratus anterior plane block with a volume of 25 ml of bupivacaine 0.25% followed by induction of general anesthesia.

Arms:

modified SAP block group

Size

Primary endpoint

tramadol consumption

at 24 hours postoperative

Eligibility criteria

Inclusion Criteria: * Patient consent. * both sex. * Age: 21-70 years old. * BMI: 18- 30 kg/m2 * ASA: I and II. * Scheduled for elective unilateral Video-Assisted thoracoscopy under general anesthesia. Exclusion Criteria: * History of allergy to the local anesthesia agents used in this study, * Skin lesion at needle insertion site, * Those receiving anticoagulant therapy or having bleeding disorders * Patients with history of chronic pain and taking analgesics, * Patients with sepsis and Significant cardiac, liver or renal diseases * Uncooperative patients or with psychiatric disorders.

Protocol

{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 99, 'type': 'ESTIMATED'}}

Updated at

2023-08-29

1 organization

1 product

2 indications

Organization

Product

Indication

Indication